These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1798933)

  • 21. Long term use of intravenous insulin because of failure of subcutaneous insulin treatment.
    Diaz-Pereda L; Yang TI; Knowles HC
    Trans Am Clin Climatol Assoc; 1979; 90():102-8. PubMed ID: 516224
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ultratard HM, a new human insulin. Advantages as compared to current preparations?].
    Saner B; Fankhauser S
    Schweiz Med Wochenschr; 1986 Jan; 116(4):116-9. PubMed ID: 3513303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of 2 therapeutic regimens using fractionated doses of insulin in insulin-dependent diabetics].
    Hajri S; Ben Slama CL; Chamakhi S; Bessioud M; Mebazaa R; Boukhris R
    Tunis Med; 1985 Nov; 63(11):589-93. PubMed ID: 3835734
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
    Goicolea I; Quiroga A; Vazquez JA
    Diabete Metab; 1987; 13(4):467-70. PubMed ID: 3315768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood and urinary glucose for optimal control of diabetes in children].
    Robert JJ; Darmaun D; Reach G; Lestradet H
    Ann Pediatr (Paris); 1986 Dec; 33(10):901-6. PubMed ID: 3548548
    [No Abstract]   [Full Text] [Related]  

  • 30. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
    Göbel P; Kramer W; Heni F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
    [No Abstract]   [Full Text] [Related]  

  • 31. Ultralente and multiple shots of regular insulin.
    Sindler B; Mersey JH
    Md Med J; 1992 Dec; 41(12):1131. PubMed ID: 1291838
    [No Abstract]   [Full Text] [Related]  

  • 32. [Practice tips for modern insulin therapy. "Bed time insulins without adverse morning aftereffect"].
    Bottermann P
    MMW Fortschr Med; 1999 Dec; 141(48):40-2. PubMed ID: 10728299
    [No Abstract]   [Full Text] [Related]  

  • 33. [Conventional insulin treatment and treatment using multiple injections in diabetes mellitus].
    Hildebrandt R; Madsbad S
    Ugeskr Laeger; 1989 Jul; 151(31):1960-7. PubMed ID: 2672490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Possibilities of therapy with various insulin preparations].
    Rabast R; Schönborn J
    Med Klin; 1976 Jun; 71(24):1023-30. PubMed ID: 933999
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 1 diabetes mellitus and the use of flexible insulin regimens.
    Hirsch IB
    Am Fam Physician; 1999 Nov; 60(8):2343-52, 2355-6. PubMed ID: 10593324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood glucose and urinary sugar in diabetic management. A comparative study].
    Christiansen KM; Vestermark S
    Ugeskr Laeger; 1983 Mar; 145(11):815-8. PubMed ID: 6344377
    [No Abstract]   [Full Text] [Related]  

  • 38. Self-monitoring of blood glucose levels in diabetes. Principles and practice.
    Bergman M; Felig P
    Arch Intern Med; 1984 Oct; 144(10):2029-34. PubMed ID: 6385899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The insulin treatment and insulin-antigenicity].
    Fankhauser S
    Med Welt; 1975 Oct; 26(40):1831-3. PubMed ID: 1186476
    [No Abstract]   [Full Text] [Related]  

  • 40. [Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?].
    Sachse G; Federlin K
    Med Klin; 1981 May; 76(11):319-23. PubMed ID: 7017364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.